OBJECTIVES: Involving stakeholders in research helps ensure that research is relevant and responsive to stakeholder needs while improving the quality of the research. This research was conducted as part of AHRQ's Community Forum project which was charged with identifying emerging strategies and state of the art methods for engaging stakeholders. METHODS: We developed a conceptual framework for stakeholder engagement that informed this literature scan and assisted in organizing findings. The scan included a search of peer-reviewed literature, using academic databases as well as an Internet search of grey literature and Web sites. Our final review included 23 peer-reviewed articles, 15 grey literature documents, and 43 Web sites related to stakeholder engagement. To supplement our scan, we conducted 11 interviews with individuals experienced in the field of stakeholder engagement. Our technical experts also suggested organizations and Web sites to explore in our literature review. RESULTS: We identified many promising methods of involving stakeholders in research. One example is using online collaborative platforms to enable interactions between an organization and its stakeholders through a virtual space. These allow users to share information, work together, and provide feedback to stakeholders about how their input is being used. Other examples include product development challenges, utilizing existing online communities, and grassroots community organizing. Selected recommended practices from our review include gaining trust of stakeholders before involvement and maintaining throughout; selecting stakeholders for whom the decision or research has important consequences; and educating stakeholders on their roles, their responsibilities, and the topics being discussed. A limitation to our findings is that there are limited evaluation data measuring outcome effectiveness of these methods. CONCLUSIONS: Stakeholder involvement is critical to health care research. This presentation will highlight selected effective and creative approaches to stakeholder engagement.
OBJECTIVES: Despite much research to understand patient nonadherence, clear research-based evidence of how to reduce non-adherence remains elusive. This paper describes two related studies conducted as part of the FP7 European Commission funded Ascertaining Barriers to Compliance (ABC) project. We sought to develop consensus-based policy solutions to address medicines adherence and benchmark current implementation activity for those policy solutions. METHODS: Delphi study: A 4-round Delphi study was conducted with 49 participants from 14 countries, representative of a range of stakeholder groups. Participants engaged in the study remotely, anonymously and electronically. Participants responded to open questions about the causes, consequences and solutions to medication non adherence. Subsequent rounds refined responses, and sought ratings of the relative importance, operational and political feasibility of each potential solution to medication nonadherence. Feedback of responses was provided to participants after each round. A consensus meeting was held to discuss and further refine the proposed policy solutions. National self-assessment study: An online survey and follow-up telephone interview were conducted based on policy solutions resulting from the consensus study. National medicines leads within the Ministries of Health for the 27 European Union member states were invited to participate. Participants rated the extent and appropriateness of implementation of each policy solution in their country. RESULTS AND CONCLUSIONS: Twenty-five policy solutions were prioritised based on composite scores for importance, operational and political feasibility. Prioritised policy solutions focused on interventions for patients, training for healthcare professionals, and actions to support patient-clinician partnership. Few solutions concerned actions by governments, health care payers, or interventions at the system level. Implementation varied across nations. Some European nations had not identified medication adherence as a priority and tended to be concerned with developing more general clinical governance arrangements. Some European nations had more systematic, co-ordinated approaches to implementing policy solutions to address medication nonadherence.
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AUSTRALIA'S RULE OF RESCUE AND THE LIFE SAVING DRUGS PROGRAMME: SAME-SAME BUT DIFFERENT?
Priest VL 1 , Dummett H 2 1 Double Helix Consulting Group, Singapore, Singapore, 2 Double Helix Consulting Group, London, UK OBJECTIVES: Medicines that are considered to be clinically effective but not costeffective by the Pharmaceutical Benefits Advisory Committee (PBAC) may be reimbursed in Australia through two pathways: by meeting the 'rule of rescue' (RoR) criteria to be listed on the Pharmaceutical Benefits Scheme, or being included on the life-saving drugs programme (LSDP). The criteria for the RoR and LSDP share some similarities, but the LSDP criteria are less subjective and more restrictive. We sought to analyse and compare outcomes for submissions that were considered under the RoR and LSDP from 2008 to 2011. METHODS: Public Summary Documents of PBAC recommendations for 2008-2011 were reviewed to identify submissions that were considered for reimbursement citing the RoR or requested listing on the LSDP. Outcomes of the applications were analysed and Payer interviews were un-A14 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 1 -A 2 5 6
